CT and MRI are used to evaluate the size and characteristics of the residual mass and tumour markers, such as alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG) and lactate dehydrogenase (LDH), to determine the response to therapy and relapse. Here, AFP is linked to neoplasm.